H2 Receptor Antagonist — Aspiration Prophylaxis
Pregnancy: Famotidine: use with caution — limited safety data; omeprazole preferred in pregnancy
Ranitidine / Famotidine (H2 Antagonist — Aspiration Prophylaxis)
Brand names: Famotidine (generic), Pepcid
Adult dose
Dose: Famotidine: 20 mg oral 2 hours pre-operatively (aspiration prophylaxis). Ranitidine: withdrawn UK (NDMA contamination) — replaced by famotidine
Route: Oral
Frequency: Single pre-operative dose
Max: 40 mg
Aspiration prophylaxis: reduces gastric acid volume and pH before anaesthesia. Often combined with sodium citrate (30 mL oral immediately pre-induction) for rapid gastric neutralisation
Paediatric dose
Dose: 0.5-1 mg/kg oral (famotidine) mg/kg
Route: Oral
Frequency: Single pre-operative dose
Max: 20 mg
Seek specialist opinion for aspiration prophylaxis dosing in paediatric anaesthesia
Dose adjustments
Renal
Reduce famotidine dose in severe renal impairment (eGFR under 30): 20 mg every 48 hours
Hepatic
No dose adjustment required
Paediatric weight-based calculator
Seek specialist opinion for aspiration prophylaxis dosing in paediatric anaesthesia
Clinical pearls
- Ranitidine was withdrawn from UK market in 2019 (MHRA) due to NDMA (N-nitrosodimethylamine) contamination — a probable human carcinogen; famotidine is the recommended alternative for aspiration prophylaxis
- Aspiration risk reduction: H2 antagonist pre-operatively reduces gastric acid secretion for 6-8 hours; target gastric pH above 2.5 and volume below 25 mL to minimise aspiration pneumonitis risk (Mendelson criteria)
- Rapid sequence induction (RSI) technique (cricoid pressure, rapid induction, immediate intubation) is the primary protection against aspiration — antacid prophylaxis is an adjunct
- Sodium citrate (30 mL oral): immediate gastric pH neutralisation (alkaline buffer) given immediately before RSI induction — complements pre-operative H2 antagonist
- NICE: Routine aspiration prophylaxis not required for all patients — reserve for high-risk groups (full stomach, emergency surgery, obesity, GORD, diabetes with gastroparesis, hiatus hernia)
Contraindications
- Hypersensitivity to H2 antagonists
Side effects
- Headache
- Dizziness
- Constipation or diarrhoea
- Elevated liver enzymes (rare)
- QT prolongation (famotidine — less than cimetidine)
Interactions
- Antacids (reduce absorption — separate by 2 hours)
- Ketoconazole / itraconazole (reduced absorption due to raised gastric pH)
- Famotidine has fewer drug interactions than cimetidine (not a CYP inhibitor)
Monitoring
- No specific monitoring required for single pre-operative dose
Reference: BNFc; BNF 90; MHRA Ranitidine Withdrawal 2019; AAGBI Preoperative Assessment Guidelines; Mendelson (1946) aspiration criteria. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
- Caprini Score for VTE Risk (2005) · VTE Risk
- Caprini VTE Risk Assessment · Venous Thromboembolism
- Khorana Score for VTE in Cancer · VTE Risk
- IMPROVE-DD VTE Risk Score · VTE Risk
- Padua Prediction Score for VTE Risk in Medical Inpatients · Venous Thromboembolism
- IMPROVE Bleeding Risk Score for Hospitalised Patients · Bleeding Risk
Pathways
- Major Trauma — Primary Survey (ATLS) · ATLS 10th Edition; JRCALC; NICE NG39
- Major Haemorrhage / Massive Transfusion · BCSH; RCOA; RCEM; RCS — BCSH Guidelines
- Lower Gastrointestinal Bleed · NICE; BSG; ACPGBI — Commissioning Guide
- Acute Pancreatitis · NICE; IAP/APA; ACPGBI — CG104
- Faecal Peritonitis · ASGBI; RCS — Best Practice
- Acute Compartment Syndrome · BAPRAS; BOA; RCS — Best Practice